Viseon Inc.
- Industry
- Medical Devices
- Founded Year
- 2017
- Headquarters
- 13700 Alton Pkwy, Suite 167, Irvine, California 92618, US
- Employee Count
- 19
Key People
- Jeffrey Valko - Co-Founder, Chief Executive Officer, President & Board Member
- Jill Pearson - Chief Financial Officer
- Pete Davis - Chief Operating Officer
- Alex Thomson - Co-Founder
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with a track record in the MedTech industry.
The presence of multiple successful MedTech entrepreneurs in the leadership team suggests a strong foundation for strategic decision-making and industry navigation.
- Clinical Need
-
Aspect: Very Strong
Summary: Viseon's products address significant gaps in surgical visualization, enhancing precision and outcomes.
By providing advanced 4K imaging solutions for minimally invasive surgeries, Viseon addresses a pressing need for better intraoperative visualization, potentially leading to improved patient outcomes.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering surgical visualization technologies, though Viseon's 4K single-use devices offer differentiation.
The surgical visualization market includes established companies; however, Viseon's focus on single-use 4K imaging systems offers a unique value proposition that may set it apart from competitors.
- Technical Challenge
-
Aspect: Predictable
Summary: The development of 4K single-use imaging devices involves manageable technical challenges.
Developing high-resolution imaging devices for surgical applications is complex but follows established technological pathways, making the challenges predictable and surmountable.
- Patent
-
Aspect: Strong
Summary: Viseon holds a robust patent portfolio with 19 patents, indicating strong intellectual property protection.
A strong patent portfolio safeguards Viseon's innovations, preventing competitors from easily replicating their technology and reinforcing their market position.
- Financing
-
Aspect: Well-funded
Summary: Viseon has secured significant funding from reputable investors, supporting its growth and development.
With investments from firms like Invus Opportunities, MedFocus, and Wexford Capital, Viseon has the financial resources necessary to advance its product development and market penetration strategies.
- Regulatory
-
Aspect: 510k/PMA
Summary: Viseon's products are subject to FDA 510(k) clearance, a standard regulatory pathway for medical devices.
Navigating the 510(k) clearance process is a well-defined route for medical devices, allowing Viseon to bring its products to market efficiently while ensuring safety and efficacy standards are met.
Opportunity Rollup
- Odds of Success
- 3.5
- Peak Market Share
- 4.4
- Segment CAGR
- 10.7%
- Market Segment
- Endoscopy Devices
- Market Sub Segment
- Surgical Visualization Systems
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.66 |
| 3 | 1.54 |
| 4 | 3.08 |
| 5 | 4.40 |
Key Takeaway
Viseon Inc. is well-positioned in the growing surgical visualization market, leveraging its innovative 4K single-use imaging technology to meet critical clinical needs and drive adoption in minimally invasive surgeries.